Wednesday, January 11, 2023
Joe Gomes, Senior Research Analyst, Noble Capital Markets, Inc.
Joshua Zoepfel, Research Associate, Noble Capital Markets, Inc.
Refer to the full report for the price target, fundamental analysis, and rating.
ICR Conference. Lifeway CEO Julie Smolyansky presented at the ICR Conference yesterday. In addition to providing a brief Company history, Ms. Smolyansky’s presentation highlighted the size and growth potential of the probiotic market. Ms. Smolyansky’s goal is to make Lifeway to kefir what Tropicana is to orange juice internationally.
Market Size. The U.S. probiotic market was $9.3 billion in 2021 and is projected to post a 7.7% CAGR from 2022-2030, providing Lifeway with a rising tide for its various probiotic products. Notably, probiotic growth is not limited to the U.S. allowing Lifeway to capture additional opportunity in various international markets.
Get the Full Report
Equity Research is available at no cost to Registered users of Channelchek. Not a Member? Click ‘Join’ to join the Channelchek Community. There is no cost to register, and we never collect credit card information.
This Company Sponsored Research is provided by Noble Capital Markets, Inc., a FINRA and S.E.C. registered broker-dealer (B/D).
*Analyst certification and important disclosures included in the full report. NOTE: investment decisions should not be based upon the content of this research summary. Proper due diligence is required before making any investment decision.
